Surveilling the threat of ovarian cancer

Currently, ovarian cancer is the fifth most frequent cause of cancer-related deaths for women in Western countries, largely due to its often illusive symptoms and lack of adequate screening methods.

“Participating in research on ovarian cancer has been a rewarding experience. I have learned what it means to be a researcher, what we do in the lab is for the greater good of society,” says Rebeca.

Dreams of a cure

Daniel comes to Canada from Guadalajara, Mexico’s Instituto Tecnológico y de Estudios Superiores de Monterrey’s Department of Biotechnology engineering on a 12-week Mitacs Globalink internship. Under the guidance of Dr. Peter Eck, from the Department of Human Nutritional Sciences, he is contributing to research on the genes implicated in complex chronic diseases such as Type 2 Diabetes.

Furthering cancer research through Globalink

“I was inspired by one of my colleagues at university who was part of the program last year and now promotes it in India.  I was lucky enough to be selected to come here to Canada for research into leukemia in children.”

Manish is about to begin his final year of studies for a Bachelor of Technology degree with a major in Biotechnology and a minor in Computer Science at the Indian Institute of Technology Guwahati.

Boosting stroke research through Mitacs Globalink

Severe brain damage induced by a stroke produces a reduction of immune functioning, which can result in fatal infections threatening the survival of patients after a stroke. Given that 20-25% of patients fall victim to infection post-stroke, this research is highly significant.

Research from the heart

Diego comes from Guadalajara, Mexico’s Monterrey Institute of Technology and Higher Education where he is working towards his undergraduate degree in Biotechnology. It was his initial intrigue with DNA that drove him to this field of study, but now the possibility that his research will have real world impact has pushed him to pursue his masters.

Canadian pharmaceutical company given start-up strength

However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.

With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.

Collaborating on a vaccine for cancer

The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.

Applying Step skills in the real world

As a PhD student in Western University's department of Physiology and Pharmacology, Gurjeev’s research focuses on uncovering molecular mechanisms that predispose low birth weight babies to increased risk of developing cardiovascular diseases in adult life.

Award Winner Interview: Joanna Triscott

Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease.  Below is an exclusive interview with Ms.

Award Winner Interview: Oualid Haddad

The research led to the completion of a motorized incubator device that now enables researchers to observe live cells for days at a time as they are stretched under the microscope.  His work may help to cure a devastating skin blistering disease called epidermolysis bullosa simplex.  Below is an exclusive interview with Mr.

Pages